News related to Pacerone (Amiodarone) and/or conditions it is approved for
HCV Antiviral Simeprevir Label Warns of Cardiac Risk
Source: theheart.org | Medscape Cardiology Headlines [2015.04.16]
The approved labeling change from the FDA warns of an increased risk of bradycardia with simeprevir when it is used in combination with amiodarone and sofosbuvir.
Oral drug normalizes blood potassium in 98 percent of kidney patients
Source: Urology / Nephrology News From Medical News Today [2015.04.02]
High potassium increases risk of fatal cardiac arrhythmiasPatients with chronic kidney disease may be treated with a class of medications called Renin Angiotensin Aldosterone System inhibitors...